NOVIZIO, NUNZIA
 Distribuzione geografica
Continente #
AS - Asia 599
NA - Nord America 233
EU - Europa 185
SA - Sud America 36
AF - Africa 3
Totale 1.056
Nazione #
HK - Hong Kong 285
SG - Singapore 244
US - Stati Uniti d'America 231
IT - Italia 56
RU - Federazione Russa 47
DE - Germania 39
BR - Brasile 34
VN - Vietnam 23
CN - Cina 21
IE - Irlanda 12
IN - India 12
FI - Finlandia 10
CZ - Repubblica Ceca 6
KR - Corea 4
NL - Olanda 4
GB - Regno Unito 3
JP - Giappone 2
NP - Nepal 2
PL - Polonia 2
SE - Svezia 2
TR - Turchia 2
UA - Ucraina 2
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
CA - Canada 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
LK - Sri Lanka 1
MA - Marocco 1
PY - Paraguay 1
SA - Arabia Saudita 1
SN - Senegal 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 1.056
Città #
Hong Kong 284
Chandler 60
Princeton 30
Ashburn 29
Singapore 27
Munich 24
Salerno 19
Dong Ket 17
Dublin 12
Pune 10
Seattle 10
Dallas 9
Turku 9
Los Angeles 8
Naples 8
Wilmington 7
Ann Arbor 6
Brno 6
Moscow 5
São Paulo 5
Ho Chi Minh City 4
Rome 4
Shanghai 4
Amsterdam 3
Carbonia 3
Columbus 3
London 3
Santa Clara 3
Ansbach 2
Avellino 2
Boardman 2
Fisciano 2
Hanoi 2
Hanover 2
New York 2
Phoenix 2
Rio de Janeiro 2
The Dalles 2
Warsaw 2
Acerra 1
Agra 1
Alvorada 1
Andover 1
Annapolis 1
Araguaína 1
Araxá 1
Araçuaí 1
Asunción 1
Augusta 1
Bari 1
Birmingham 1
Boca Toma 1
Bom Jesus de Goiás 1
Boston 1
Brooklyn 1
Camaçari 1
Campinas 1
Canoas 1
Canoinhas 1
Casablanca 1
Charlotte 1
Chicago 1
Contagem 1
Cuiabá 1
Dakar 1
Dalian 1
Dammam 1
Esslingen am Neckar 1
Etobicoke 1
Falkenstein 1
Florence 1
Fortaleza 1
Gebze 1
Guangzhou 1
Handan 1
Hengshui 1
Itaquaquecetuba 1
Izmir 1
Jhāpā 1
Jinhua 1
João Pessoa 1
Kathmandu 1
Landshut 1
Lappeenranta 1
Ludhiana 1
Medina 1
Nanjing 1
Napoli 1
Nuremberg 1
Orlando 1
Osaka 1
Osasco 1
Paulínia 1
Piemonte 1
Praia Grande 1
Recife 1
Ribeirão Preto 1
Richmond 1
Rio Branco 1
Salvador 1
Totale 695
Nome #
The promising pro-healing role of the association of mesoglycan and lactoferrin on skin lesions 217
Annexin A1 Is Involved in the Antitumor Effects of 5-Azacytidine in Human Oral Squamous Carcinoma Cells 210
Anxa1 contained in evs regulates macrophage polarization in tumor microenvironment and promotes pancreatic cancer progression and metastasis 137
Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors 83
Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells 82
Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2 61
Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro 60
The procoagulant activity of emoxilane®: A new appealing therapeutic use in epistaxis of the combination of sodium hyaluronate, silver salt, α-tocopherol and d-panthenol 60
Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity 42
The Protecting Activity of RIPACUT®: A New Therapeutic Approach Preserving Epithelial Health Based on the Combination of Iceland Lichen Extract, Silver Salt, and Sodium Hyaluronate 38
The combination of mesoglycan and VEGF promotes skin wound repair by enhancing the activation of endothelial cells and fibroblasts and their cross-talk 35
The pyrazolyl-urea gege3 inhibits the activity of ANXA1 in the angiogenesis induced by the pancreatic cancer derived EVs 33
The pro-healing effects of heparan sulfate and growth factors are enhanced by the heparinase enzyme: New association for skin wound healing treatment 19
Metformin radiosensitizes OSCC in 2D and 3D models: possible involvement of CAF-1 16
Totale 1.093
Categoria #
all - tutte 3.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 1 0 0 8 1 2 1 0 30
2021/202272 7 0 0 13 7 3 0 2 3 0 7 30
2022/2023132 10 22 5 25 9 24 0 8 12 4 10 3
2023/202496 5 6 3 1 3 25 8 15 2 3 2 23
2024/2025421 5 7 2 7 7 27 48 9 38 31 133 107
2025/2026329 76 253 0 0 0 0 0 0 0 0 0 0
Totale 1.093